| Literature DB >> 26490319 |
Isabel Gonçalves1,2, Elisavet Andersson Georgiadou3, Sören Mattsson4, Göran Skog5, Luís Pedro6, José Fernandes E Fernandes6, Nuno Dias7, Gunnar Engström8, Jan Nilsson1, Kristina Stenström3.
Abstract
Mediterranean diet has been suggested to explain why coronary heart disease mortality is lower in southern than northern Europe. Dietary habits can be revealed by isotope ratio mass spectrometry (IRMS) measurement of carbon (δ(13)C) and nitrogen (δ(15)N) in biological tissues. To study if diet is associated with human plaque stability, atherosclerotic plaques from carotid endarterectomy on 56 patients (21 Portuguese and 35 Swedish) were analysed by IRMS and histology. Plaque components affecting rupture risk were measured. Swedish plaques had more apoptosis, lipids and larger cores, as well as fewer proliferating cells and SMC than the Portuguese, conferring the Swedish a more rupture-prone phenotype. Portuguese plaques contained higher δ(13)C and δ(15)N than the Swedish, indicating that Portuguese plaques were more often derived from marine food. Plaque δ(13)C correlated with SMC and proliferating cells, and inversely with lipids, core size, apoptosis. Plaque δ(15)N correlated with SMC and inversely with lipids, core size and apoptosis. This is the first observational study showing that diet is reflected in plaque components associated with its vulnerability. The Portuguese plaques composition is consistent with an increased marine food intake and those plaques are more stable than those from Swedish patients. Marine-derived food is associated with plaque stability.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26490319 PMCID: PMC4614889 DOI: 10.1038/srep15524
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Generalized isotopic trophic diagram for terrestrial and marine food webs34. (b) Stable isotope (δ13C and δ15Ν) diagram for Portuguese and Swedish plaques.
Clinical characteristics of the patients that underwent carotid endarterectomy. SD, standard deviation; NS, non-significant.
| Swedish patients operated 2005-2011 (n = 35) | Portuguese patients operated 2000-2001 (n = 21) | P value | |
|---|---|---|---|
| Age (years) | 73.7 (SD 9.7) | 69.0 (SD 10.6) | NS |
| Gender (males) | 23 (66%) | 16 (76%) | NS |
| Symptoms | 27 (77%) | 13 (62%) | NS |
| Time between symptoms and operation (days) | 29.2 (SD 29.4) | 10.0 (SD 10.8) | 0.005 |
| Degree of stenosis (%) | 87 (SD 9.8) | 83 (SD 7.3) | NS |
| Type 2 diabetes | 16 (46%) | 6 (29%) | NS |
| Hypertension | 26 (74%) | 20 (95%) | NS |
| Smoking (currently) | 12 (34%) | 4 (19%) | NS |
| Statin use | 22 (63%) | 5 (24%) | 0.006 |
| Fasting lipoproteins (mmol/L): | |||
| Cholesterol | 4.4 (SD 1.2) | 5.3 (SD 1.4) | NS |
| Low-density lipoprotein (LDL) | 2.7 (SD 1.0) | 2.9 (SD 1.4) | NS |
| High-density lipoprotein (HDL) | 1.1 (SD 0.4) | 0.9 (SD 0.4) | NS |
| Triglycerides | 1.5 (SD 0.8) | 1.5 (SD 0.2) | NS |
Figure 2Boxplots showing the histological analysis of carotid plaque components (% area) from Portuguese (in red) and Swedish (in blue) patients: (a) apoptosis (TUNEL, P < 0.0001), lipids (Oil Red O, P < 0.001) and core (P = 0.03), (b) smooth muscle cells (alpha-actin, P < 0.0001) and proliferative cells (PCNA, P < 0.0001).
Figure 3Representative images of a Swedish (a,b) and a Portuguese (c,d) carotid plaque stained for lipids (in red, Oil Red O; left panel) and for smooth muscle cells (SMCs, in brown, alpha-actin; right panel). Scale bar 500 μm.
Figure 4Boxplots showing (a) δ13C levels (P < 0.00001) and (b) δ15Ν levels in carotid plaques from Portuguese and Swedish patients (P < 0.0001).
Correlations between the stable isotope ratios δ13C and δ15N and the different human atherosclerotic plaque components assessed histologically and immunohistochemically. NS, non-significant.
| Area of component | Non-adjusted | Adjusted | ||
|---|---|---|---|---|
| δ13C | δ15N | δ13C | δ15N | |
| Core | −0.323§ | −0.311§ | −0.186† | −0.272‡ |
| Lipids (Oil Red O) | −0.41§ | −0.256‡ | −0.328§ | −0.186† |
| Apoptosis (TUNEL) | −0.516§ | −0.374§ | −0.457§ | −0.328§ |
| Macrophages (CD68) | NS | 0.201† | NS | NS |
| Smooth muscle cells (alpha-actin) | 0.769§ | 0.437§ | 0.361§ | 0.227‡ |
| Proliferating cells (PCNA) | 0.423§ | NS | −0.188† | NS |
*Adjusted for age, gender, country, current smoker and diabetes. †P < 0.05; ‡P < 0.01; §P < 0.0001.